HOME >> MEDICINE >> NEWS
Treatment-Resistant Depression: Results of Latest Electromagnetic Stimulation Study Show Promise

WASHINGTON, D.C. -- An investigational treatment employing electromagnetic stimulation relieved depression in 25 patients whose depression failed to respond to conventional treatment, report Emory University researchers at this week's American Psychiatric Association meeting.

Scores on depression rating scales administered to study subjects before, during and after the new treatment "were significantly improved at all time points compared to baseline," says first author Yvonne M. Greene, M.D., in the abstract; Dr. Greene is a neurosciences fellow at the Emory University School of Medicine and has collaborated on the open trial with William McDonald, M.D., associate professor of psychiatry and behavioral sciences at the Emory University School of Medicine, and others.

"Sixty-four percent of patients were rated 'very much improved' or 'much improved' on the (CGIC) Clinical Global Impression of Change and 40 percent of patients had an equal to or greater than 50 percent decrease in HDRS (Hamilton Depression Rating Scale) scores at the end of treatment week two. Forty percent of patients were rated 'very much improved' or 'much improved' on the CGIC and 32 percent of patients had an equal to or greater than 50 percent decrease in HDRS scores at the end of the four-week followup.

"These results suggest rTMS (repetitive transcranial magnetic stimulation) may be a viable option for patients with treatment-resistant depression," the authors say.

Prior to receiving rTMS, "There were an average of seven antidepressant failures per patient and eight patients had failed electroconvulsive therapy (ECT)," they say.

"rTMS involves passing current through an electromagnetic coil to generate a magnetic field," they explain. "The magnetic field acts as the medium between electricity in the coil and induced electrical currents in the brain. The current depolarizes neurons in the brain up to a depth of about two centim
'"/>

Contact: Sarah Goodwin
sgoodwi@emory@emory.edu
404-727-3366
Emory University Health Sciences Center
17-May-1999


Page: 1 2

Related medicine news :

1. Heart transplant survival: Results may be key to rejection prevention, detection, treatment
2. Docetaxel versus paclitaxel in breast cancer Results of worlds first head to head trial
3. Results from first clinical trial using GVG to treat addiction
4. Results of first chronic treatment study with oral EXANTA(TM) (ximelagatran)
5. Media Advisory-- Results of California autism epidemiology study to be unveiled
6. Results of Yale study confirm aspirin helpful in preventing a first heart attack
7. Results of NUVANCE (IL-4 receptor) in Phase I/II study in asthma patients featured at AAAAI Late-Breaker Abstract and Asthma Therapy Sessions
8. Yale study shows way to re-stimulate brain cell growth: Results could boost understanding of Alzheimers, other brain disorders
9. Results of NUVANCE phase I/II asthma trial presented
10. ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia
11. UI Study Yields Encouraging Results For New Breast Cancer Treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/19/2019)... ... November 19, 2019 , ... Bright Day Big Blocks, ... children is announcing the launch of their Gift Of Play initiative. Organizations are ... be theirs. , Co-Founders of Bright Day Big Blocks, Laurel Tucker and David Krishock ...
(Date:11/19/2019)... ... November 19, 2019 , ... iPatientCare, a pioneer ... Patient Engagement solutions, announces Virtual User Conference (VUCON), which will highlight the impact ... better patient-centric experience. , VUCON sessions are designed to demonstrate ...
(Date:11/16/2019)... VEGAS (PRWEB) , ... November 15, 2019 , ... ... seen before in the United States, access to cannabis via well-managed dispensaries becomes ... marijuana industry. Wise Business Plans, industry-leading online provider of state-of-the-art, online, custom cannabis ...
(Date:11/15/2019)... (PRWEB) , ... November 15, 2019 , ... ... over 100 employers in Newsday’s Top Long Island Workplaces for 2019. The recently ... , During the selection process, Newsday worked in partnership with Energage to conduct ...
(Date:11/14/2019)... ... 14, 2019 , ... EMulate Therapeutics, Inc., a clinical-stage therapeutic ... will have 5 poster presentations related to its medical devices for treating adult ... Meeting in Phoenix, beginning on November 20 . , Two posters ...
Breaking Medicine News(10 mins):
(Date:11/15/2019)... ... ... Unlike fine wine, shoulder joints do not get better with age. Risks ... – rise after age 50, says orthopedic surgeon Alejandro Badia MD , a ... uppermost tendon of the rotator cuff – the supraspinatus tendon and its lubricating tissue ...
(Date:11/15/2019)... ... , ... Mold doesn’t need things to be wet in order to grow; ... the eye or by touch. ServPro in Cayucos , the mold damage specialist, ... conditions that mold needs to grow and how to prevent those conditions. , Mold ...
(Date:11/14/2019)... ... November 14, 2019 , ... Algae Health Sciences, a division ... using AstaZine® on brain health. , In the first study (done ... fatigue and overall mood state [psychological well-being] were found after 8 weeks in ...
Breaking Medicine Technology:
Cached News: